YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Merck MRK and Moderna MRNA delivered a significant breakthrough in melanoma treatment, with their jointly developed mRNA cancer vaccine showing positive results in its first-ever Phase 3 trial. This vaccine, combined with Merck's exemplary…
[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [http…
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…
Moderna’s vaccine candidate targets a species of ebolavirus behind a deadly outbreak in the Democratic Republic of the Congo. Continue Reading
Moderna’s vaccine candidate targets a species of ebolavirus behind a deadly outbreak in the Democratic Republic of the Congo. Continue Reading
The biotech industry has held up well this year despite macroeconomic uncertainty, pricing pressures and regulatory challenges. Strong first-quarter earnings, new drug approvals and encouraging clinical trial updates have kept investor sen…
[Bubble] Petrovich9 The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left investors struggling to determine whether th…
Key Points Interested in iShares Genomics Immunology and Healthcare ETF? Here are five stocks we like better. The field of genomics is on the verge of major breakthroughs that could revolutionize drug creation, disease detection, and more.…
Crystal Adam, President of R&D at Tango Therapeutics(NASDAQ:TNGX), reported the exercise of 27,000 stock options -- with the underlying common shares immediately sold for approximately $572,000 -- according to an SEC Form 4 filing on April…
Francis Lo, Chief People Officer at Adaptive Biotechnologies(NASDAQ:ADPT), reported the sale of a combined 68,667 shares of common stock across two transactions in early March 2026, as disclosed in a pair of SEC Form 4 filings. Transaction…
Concerns about the disruptive impact of artificial intelligence resurfaced on Feb. 23, 2026, triggering a selloff in delivery, payments and software stocks. The wave of anxiety pushed International Business Machines IBM to its steepest dec…
Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based exchange-traded fund (ETF) iShares Biotechno…
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American…
[Boy getting a flu or coronavirus vaccine in the clinic] Luis Alvarez A Centers for Disease Control and Prevention webpage now indicates that vaccines may cause autism, reversing its prior language on the matter, as "studies supporting a l…
[artificial intelligence Digital transformation change management, internet of things. man using computer and holding virtual ai diagram in concept of smart industry and Ai technology] cherdchai chawienghong/iStock via Getty Images Morgan…
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be acquired by Merck & Company, Inc. (NYSE:MRK) for $47 per share in cash. The acquisition price translates to an equity val…
Vir Biotechnology, Inc. (VIR) jumped as much as 20% on Wednesday after announcing that it will join the S&P SmallCap 600 on April 4. Vir is currently held by 66 ETFs. A total of 8 million shares are currently held in exchange-traded funds.…
Today, BlackRock’s iShares arm released its report on the megatrend themes it expects to see accelerating in 2022 and beyond. Those three trends include digital transformation, automation and next-generation oncology. Much of that accelera…
Biotech companies use or modify biological processes in order to create new pharmaceuticals or therapies. The biotech sector is particularly closely followed right now as a number of biotech companies around the world rush to develop poten…